Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9214767Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Public Health
NIH Funding · FY2025
Linked Award Amount
$1.6M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#9,048
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Jeffrey David Klausner as a PI. Multi-PI records show the full award amount for context.
- 4R01AI155217-06R01Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis$702.1Kaward amount
- 5R01AI139265-07R01Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design$433.7Kaward amount
- 1D43TW012743-01A1D43V-STAR - Vietnam Research Training Program on Sexually Transmitted Diseases and Antimicrobial Resistance$246.1Kaward amount
- 3R01AI139265-07S1R01Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design$240.6Kaward amount
Award organization
Organizations that administered FY2025 awards listing Jeffrey David Klausner as a PI.
FY2025 award administered by University of Southern California (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Southern California
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4810
- 2024Entered Top 25% NationallyRanked #4810
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jeffrey David Klausner.